Atlas Trials

Study of MLN8237 in Participants With Advanced Hematological Malignancies

Clinical trial NCT00697346 · COMPLETED

Trial details

NCT number
NCT00697346
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
B-cell Follicular LymphomaB-cell Marginal Zone LymphomaDiffuse Large B-cell LymphomaB-cell Mantle Cell LymphomaB-cell Small Lymphocytic LymphomaB-Cell Chronic Lymphocytic LeukemiaMultiple MyelomaWaldenstrom's MacroglobulinemiaNoncutaneous Peripheral T-cell Lymphoma Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaAnaplastic Large Cell LymphomaEnteropathy Associated T-cell Lymphoma
Start date
2008-07-11
Primary completion
2016-10-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.